Nicorandil Attenuates Reperfusion Injury after Long Cardioplegic Arrest
Authors:
- 1 June 2007
- journal article
- research article
- Published by SAGE Publications in Asian Cardiovascular and Thoracic Annals
- Vol. 15 (3) , 204-209
Abstract
The cardioprotective efficacy of nicorandil in cardiac surgery was determined using a surgically relevant 4-hr cardioplegic arrest model. Each isolated rabbit heart was parabiotically blood-perfused using a modified Langendorff column. The magnitude of left ventricular developed pressure and rate of change of developed pressure over time were measured before (baseline) and after ischemia. Nicorandil was administered either pre-ischemia, post-ischemia, pre/post-ischemia, or continuously (before, during, and after ischemia). The endothelium of the coronary artery was observed by scanning electron microscopy. Serum myeloperoxidase activities were also measured. Although pretreatment with nicorandil did not affect recovery of developed pressure, administration of nicorandil after ischemia, or before and after ischemia, enhanced the recovery of developed pressure. Serum myeloperoxidase activity was decreased in the pre/post-ischemia and continuous groups. Endothelial reperfusion injury decreased in all nicorandil-treated groups. Administration of nicorandil attenuated ischemia-reperfusion injury of the myocardium and coronary endothelium while ameliorating leukocyte activation. In the event of unexpected prolonged cardioplegic arrest, administration of nicorandil, even just after declamping, may improve cardiac function. However, pre-ischemia administration alone was not helpful in the heart subjected to prolonged cardioplegic arrest.Keywords
This publication has 18 references indexed in Scilit:
- Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trialThe Lancet, 2002
- Nicorandil, a potent cardioprotective agent, reduces QT dispersion during coronary angioplastyAmerican Heart Journal, 2001
- Selective mitochondrial adenosine triphosphate–sensitive potassium channel activation is sufficient to precondition human myocardiumThe Journal of Thoracic and Cardiovascular Surgery, 2000
- Three minute, but not one minute, ischemia and nicorandil have a preconditioning effect in patients with coronary artery diseaseJACC, 2000
- Preconditioning by Mitochondrial ATP-Sensitive Potassium Channel Openers : An Effective Approach for Improving the Preservation of Heart TransplantsCirculation, 1999
- Myocardial Protection Afforded by Nicorandil and Ischaemic Preconditioning in a Rabbit Infarct Model In VivoJournal of Cardiovascular Pharmacology, 1998
- Nicorandil reduces myocardial infarct size by opening the Katp channel in rabbitsInternational Journal of Cardiology, 1997
- Increased Tolerance of the Chronically Hypoxic Immature Heart to IschemiaCirculation, 1997
- Bimakalim, an ATP-Sensitive Potassium Channel Opener, Mimics the Effects of Ischemic Preconditioning to Reduce Infarct Size, Adenosine Release, and Neutrophil Function in DogsCirculation, 1995
- EFFECT OF NICORANDIL ON POST‐ISCHAEMIC CONTRACTILE DYSFUNCTION IN THE HEART: ROLES OF ITS ATP‐SENSITIVE K’ CHANNEL OPENING PROPERTY AND NITRATE PROPERTYClinical and Experimental Pharmacology and Physiology, 1993